Abstract
Objective
TO investigate fetal-placental cocaine clearance, and to determine the fetal catecholamine and cardiovascular responses to continuous intravenous cocaine infusion in fetal sheep.
Methods
Eleven pregnant ewes and their fetuses (121 ± 2 days’ gestation; term 150 days) were chronically instrumented. Fetuses received intravenous cocaine at 0.05, 0.1, or 0.2 mg/kg/minute. Fetal cardiovascular and hematologic measurements were made before and serially for 90 minutes after initiation of the cocaine infusion.
Results
Steady-state fetal plasma cocaine concentrations were observed by 15 minutes of infusion and averaged 136 ± 77, 318 ± 65, and 610 ± 36 ng/mL, respectively, at each dose. Fetal-placental cocaine clearance rate was independent of dose (331 ± 39 mL/kg/minute), indicating that it is a first-order pharmacokinetic process. Fetal plasma concentration of benzoylecgonine, a principle cocaine metabolite, increased throughout the study to approximately 25% above cocaine levels by 90 minutes. Tliere were significant increases in fetal heart rate (from 169 ± 11 to 242 ±36 beats per minute), mean blood pressure (from 53 ± 4 to 63 ± 5 mmHg), and systolic blood pressure (from 68 + 2 to 80 ± 5 mmHg), with a corresponding increase in catecholamine levels seen in the fetuses infused with 0.2 mg/kg/minute. These changes were not seen in the fetuses given lower doses of cocaine.
Conclusion
Fetal-placental clearance of cocaine is a rapid, first-order pharmacokinetic process. During prolonged cocaine exposure, plasma benzoylecgonine concentrations accumulate significantly. Significant catecholamine and cardiovascular changes are seen in fetal sheep with a continuous infusion of cocaine at 0.2 mg/kg/minute or greater. (J Soc Gynecol Invest 1996;3:185-90)
Similar content being viewed by others
References
Acker D, Sachs BP, Tracey KJ, et al. Abruptio placentae associated with cocaine use. Am J Obstet Gynecol 1983;146:220–1.
Ney JA, Dooley SL, Keith LG, et al. The prevalence of substance abuse in patients with suspected preterm labor. Am J Obstet Gynecol 1990;162:1562–7.
Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine on fetal growth. N Engl J Med 1989;320:762–8.
Henderson MG, McMillen BA. Effects of prenatal exposure to cocaine or related drugs on rat development and neurologic indices. Brain Res Bull 1990;24:207–12.
Chasnoff LJ, Hunt CE, Kletter R, Kaplan D. Prenatal cocaine exposure is associated with respiratory pattern abnormalities. Am J Dis Child 1989,143:583–7.
DeVane CL, Simpkins JW, Miller RL, Braun SB. Tissue distribution of cocaine in the pregnant rat. Life Sci 1989;45:1271–6.
Robinson SE, Enters EK, Jackson GF, et al. Maternal and fetal brain and plasma levels of cocaine and benzoylecgonine after acute or chronic maternal intravenous administration of cocaine. J Pharm Exp Ther 1994;217:1234–9.
Burchfield DJ, Graham EM, Abrahms RM, Gerhardt KJ. Cocaine alters behavioral states in fetal sheep. Dev Brain Res 1990;56:41–5.
Burchfield DJ, Abrams RM. Cocaine depresses cerebral glucose utilization in the fetal sheep. Brain Res 1993;73:283–8.
Chan K, Dodd P, Day L, et al. Fetal catecholamine, cardiovascular and neurobehavioral responses to cocaine. Am J Obstet Gynecol 1992;167:1616–23.
DeVane CL, Burchfield DJ, Abrams RM, Miller RL, Braun SB. Disposition of cocaine in pregnant sheep. Dev Pharmacol Ther 1991;16:123–9.
Covert RF, Schreiber MD, Tebbet IR, Torgerson LJ. Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs. J Pharmacol Exp Ther 1994;270:118–26.
Woods JR, Plessinger MA, Scott K, Miller RK. Prenatal cocaine exposure to the fetus: A sheep model for cardiovascular evaluation. Ann N Y Acad Sci 1989;562:267–79.
Yonetani M, Huang CC, Lajevardi N, Pastuszko A, Delivoria-Papdopoulous M, Anday E. Effect of acute cocaine injection on the extracellular level of dopamine, blood flow, and oxygen pressure in brain of newborn piglets. Biochem Med Metab Biol 1994;51:91–7.
Schalzo FM, Pirmozic S, Burge LJ, et al. Effects of labetalol on cocaine pharmacokinetic in neonatal piglets. Dev Pharm Ther 1993;20:54–63.
Sandberg JA, Olsen GD. Cocaine pharmacokinetics in the pregnant guinea pig. J Pharmacol Exp Ther 1991;258:477–82.
Sandberg JA, Olsen GD. Cocaine and metabolite concentration in the fetal guinea pig after chronic maternal cocaine administration. J Pharmacol Exp Ther 1992;260:587–91.
Binienda Z, Bailey JR, Duhart HM, Sliker W, Paule MG. Transplacental pharmacokinetics and maternal/fetal plasma concentrations of cocaine in pregnant macaques near term. Drug Metab Dispos 1993;21:364–8.
Duhart HM, Fogle CM, Gillam MP, Bailey JR, Slikker W, Paule MG. Pharmacokinetics of cocaine in the pregnant and nonpregnant rhesus monkey. Repro Tox 1993;7:429–37.
DiStefano JJ. Noncompartmental vs compartmental analysis: Some bases for choice. Am J Phys 1982;12:R1–6.
Ross MG, Sherman DJ, Day L, Humme J. Stimuli for fetal swallowing factors. Am J Obstet Gynecol 1989;161:1559–65.
Robillard JE, MatsonJR, Session C, Smith FG. Developmental aspects of renal tubular reabsorption of water in lamb fetuses. Pediatr Res 1979;13:1172–6.
Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine, and dopamine. Life Sci 1977;21:625–36.
Sandberg JA, Olson GD. Microassay for the simultaneous determination of cocaine, norcaine, benzoylecgonine, and benzoylnorecgonine by high-performance liquid chromatography. J Chromatogr 1990;525:113–21.
Varian Sample Preparation Products. Cocaine and benzoylecgonine extraction procedure. Bond Elut Certify instruction manual. Harbor City, California: Varian, 1994:5.
Pitts DK, Marwah J. Neuropharmacology of cocaine: Role of monoaminergic systems. Monogr Nueral Sci 1987;13:34–54.
Schenker S, Yang Y, Johnson RF, Downing JW, Schenken RS, Henderson GI, King TS. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther 1993;53:329–39.
Edwards DJ, Bowles SK. Protein binding of cocaine in human serum. Pharm Res 1988;5:440–2.
Roe DA, Little BB, Bawdon RE, Gilsrap LC. Metabolism of cocaine by human placentas: Implications for fetal exposure. Am J Obstet Gynecol 1990;163:715–8.
Ambre J. the urinary excretion of cocaine and metabolites in humans: A kinetic analysis of published data. J Anal Toxicol 1985;9:241–5.
Mahone PR, Scott K, Sleggs G, D’Antoni T, Woods JR. Cocaine and metabolites in amniotic fluid may prolong fetal drug exposure. Am J Obstet Gynecol 1994;171:465–9.
Madden JA, Powers RH. Effect of cocaine and cocaine metabolites on cerebral arteries in-vitro. Life Sci 1990;46:635–45.
Schreiber MD, Maden JA, Covert RF, Torgerson LJ. Effects of cocaine, benzoylecgonine, and cocaine metabolites on cannulated pressurized fetal sheep cerebral arteries. J Appl Physiol 1994;77:834–9.
Spear LP, Frambes NA, Kirstein CL. Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic subcutaneous administration of cocaine during gestation in rats. Psychopharmacology 1989;97:427–31.
Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. J Pediatr 1989;115:770–8.
Author information
Authors and Affiliations
Additional information
Supported by a grant from the USFHS DA-07753 and a Perinatal Biology Training Grant HD-07013.
Rights and permissions
About this article
Cite this article
Downs, T., Padbury, J., Blount, L. et al. Ovine Fetal-Placental Cocaine Pharmacokinetics During Continuous Cocaine Infusion. Reprod. Sci. 3, 185–190 (1996). https://doi.org/10.1177/107155769600300405
Published:
Issue Date:
DOI: https://doi.org/10.1177/107155769600300405